| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |